Skip to main content

previous disabled Page of 8
and
  1. No Access

    Article

    Temporal Trends in Survival Outcomes for Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy: A 14-Year Analysis

    The prognosis for patients with esophageal cancer who received neoadjuvant chemoradiotherapy (nCRT) followed by surgery has shown improvement in recent years. We sought to identify the critical factors contrib...

    Chong Beng Ng MD, Chien-Hung Chiu MD, Chi-Ju Yeh MD in Annals of Surgical Oncology (2024)

  2. Article

    Open Access

    Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement

    High-grade B-cell lymphoma (HGBCL), the subtype of non-Hodgkin lymphoma, to be relapsed or refractory in patients after initial therapy or salvage chemotherapy. Dual dysregulation of MYC and BCL2 is one of the...

    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, **** Wang, Ying Liang, **ao**g Yan in BMC Cancer (2024)

  3. Article

    Open Access

    The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer

    Patients with breast cancer (BC) at advanced stages have poor outcomes because of high rate of recurrence and metastasis. Biomarkers for predicting prognosis remain to be explored. This study aimed to evaluate...

    **-hui Ye, Jian Yu, Ming-ying Huang, Yue-mei Mo in Breast Cancer (2024)

  4. Article

    Open Access

    Ethanol responsive lnc171 promotes migration and invasion of HCC cells via mir-873-5p/ZEB1 axis

    Long nonconding RNAs (lncRNAs) have been found to be a vital regulatory factor in the development process of human cancer, and could regarded as diagnostic or prognostic biomarkers for human cancers. Here, we ...

    Shi** Huang, Zhouxiang Liao, **ao He, Zhenyu Song, ** Fang, Sha Wen in BMC Cancer (2024)

  5. Article

    Open Access

    Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States

    Cancer survivors have a high risk of mortality, and vitamin D (VD) is associated with the risk of mortality. This study is aim to examine the impact of VD on mortality in cancer survivors.

    **aofei Mo, Chen He, Fengfeng Han, Hui Yan, Xueqin Chen, Yuetao Wang in BMC Cancer (2024)

  6. Article

    Open Access

    Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer

    Aberrant expressions of desmoglein 2 (Dsg2) and desmocollin 2(Dsc2), the two most widely distributed desmosomal cadherins, have been found to play various roles in cancer in a context-dependent manner. Their s...

    Ji-Yuan Han, Na Che, **g Mo, Dan-Fang Zhang, **ao-Hui Liang, Xue-Yi Dong in BMC Cancer (2024)

  7. Article

    Open Access

    siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression

    Breast cancer, the most prevalent cancer in women worldwide, faces treatment challenges due to drug resistance, posing a serious threat to patient survival. The present study aimed to identify the key molecule...

    Prakash Chaudhary, Kiran Yadav, Ho ** Lee, Keon Wook Kang in Breast Cancer Research (2024)

  8. Article

    Open Access

    Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma

    To evaluate the efficacy of next-generation sequencing (NGS) in minimal-residual-disease (MRD) monitoring in Chinese patients with multiple myeloma (MM).

    Mo Zhou, Yan Chen, Yanlei Gong, Mingqing Zhu, Jiannong Cen, **lan Pan in Discover Oncology (2024)

  9. No Access

    Article

    ASO Author Reflections: Clinical Value of Navigation Systems for RAPN and LPN Procedures

    Wangmin Liu MBBS, Enchong Zhang MD, PhD, Mo Zhang MD, PhD in Annals of Surgical Oncology (2024)

  10. No Access

    Article

    Current Application of Navigation Systems in Robotic-Assisted and Laparoscopic Partial Nephrectomy: Focus on the Improvement of Surgical Performance and Outcomes

    Kidney cancer represents the third most prevalent malignancy among all types of genitourinary cancer worldwide. Currently, there is a growing trend of employing partial nephrectomy for the management of large ...

    Wangmin Liu MBBS, Enchong Zhang MD, PhD, Mo Zhang MD, PhD in Annals of Surgical Oncology (2024)

  11. Article

    Open Access

    Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

    Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments.

    Xuanbo Da, Bang** Cao, Jiantao Mo, Yukai **ang, Hai Hu, Chen Qiu in BMC Cancer (2024)

  12. Article

    Open Access

    Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma

    There are limited and no standard therapies for recurrent glioblastoma. We herein report the antitumour activity and safety of sintilimab, bevacizumab and temozolomide (TMZ) in recurrent glioblastoma.

    Yinghao Lu, Limin Liao, Kunpeng Du, Jianhua Mo, **a Zou, Junxian Liang in BMC Cancer (2024)

  13. Article

    Open Access

    Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial

    Supraclavicular nodal (SCL) irradiation is commonly used for patients with high-risk breast cancer after breast surgery. The Radiation Therapy Oncology Group (RTOG) and European Society for Radiotherapy and On...

    Li Zhang, **n Mei, Zhigang Hu, Bo Yu, Chaoyang Zhang, Yong Li, Kaitai Liu in BMC Cancer (2024)

  14. No Access

    Article

    Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study

    We conducted a trial to evaluate the efficacy and safety of nivolumab and paclitaxel as second-line therapy for immune-related biomarker-enriched advanced gastric cancer (AGC).

    Choong-kun Lee, Jii Bum Lee, Se Jung Park, **gmin Che, Woo Sun Kwon in Gastric Cancer (2024)

  15. Article

    Open Access

    Prognostic potential of preoperative circulating tumor cells to predict the early progression recurrence in hepatocellular carcinoma patients after hepatectomy

    The role of circulating tumor cells (CTCs) in prognosis prediction has been actively studied in hepatocellular carcinoma (HCC) patients. However, their efficiency in accurately predicting early progression rec...

    Zhan Lu, Hanghang Ni, **hua Yang, Lihao Tan, Haixiao Zhuang, Yunning Mo in BMC Cancer (2023)

  16. Article

    Open Access

    Novel diagnostic biomarkers of oxidative stress, immune- infiltration characteristics and experimental validation of SERPINE1 in colon cancer

    Colon cancer (CC) is a prevalent malignant tumor that affects the colon in the gastrointestinal tract. Its aggressive nature, strong invasiveness, and rapid progression make it a significant health concern. In...

    Kaisheng Yuan, Di Hu, **aocong Mo, Ruiqi Zeng, Bing Wu, Zunhao Zhang in Discover Oncology (2023)

  17. Article

    Open Access

    The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer

    Although the current European Association of Urology(EAU) guideline recommends that patients with intermediate-risk non-muscle-invasive bladder cancer (NMIBC) should accept intravesical chemotherapy or Calmett...

    Jian-**n Chen, Wen-Ting Huang, Qing-Yun Zhang, Cheng-En Deng, Jue-ling Wei in BMC Cancer (2023)

  18. Article

    Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions

    Current guidelines recommend indefinite imatinib treatment for advanced gastrointestinal stromal tumor (GIST) patients. Imatinib-refractory progression-free survival (PFS) and overall survival were previously ...

    Yoon-Koo Kang, Hyung-Don Kim, Hyun ** Kim, Young Soo Park, Mo-Youl Beck in Gastric Cancer (2023)

  19. Article

    Open Access

    Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer

    Breast cancer is a malignant tumour that seriously threatens women’s life and health and exhibits high inter-individual heterogeneity, emphasising the need for more in-depth research on its pathogenesis. While...

    Qinghua Huang, Jianlan Mo, Huawei Yang, Yinan Ji, Rong Huang, Yan Liu in BMC Cancer (2023)

  20. Article

    Open Access

    Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosis

    Ferroptosis is a mode of programmed cell death that plays a crucial role in tumor biology processes. Although tetrandrine citrate (TetC) has been demonstrated to exert anti-tumor effects, it is still unclear w...

    **aocong Mo, Di Hu, Kaisheng Yuan, Juyu Luo, Cheng Huang, Meng Xu in Discover Oncology (2023)

previous disabled Page of 8